1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with Substance Withdrawal Syndrome in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cong, B; Li, S; Ma, C; Meng, Y; Ni, Z; Wen, D; Yu, H | 1 |
Berger, JE; Helton, DR; Rasmussen, K; Scearce, E | 2 |
Czachura, JF; Helton, DR; Kallman, MJ; Rasmussen, K | 1 |
Bourin, M; Colombel, MC; Malinge, M; Vasar, E | 1 |
5 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and Substance Withdrawal Syndrome
Article | Year |
---|---|
Effects of exogenous cholecystokinin octapeptide on acquisition of naloxone precipitated withdrawal induced conditioned place aversion in rats.
Topics: Animals; Conditioning, Psychological; Devazepide; Male; Morphine Dependence; Naloxone; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Spatial Behavior; Substance Withdrawal Syndrome | 2012 |
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.
Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Reflex, Startle; Substance Withdrawal Syndrome | 1993 |
The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response.
Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors | 1994 |
The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle.
Topics: Animals; Hormone Antagonists; Male; Nicotine; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome | 1996 |
Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.
Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan | 1999 |